vacina de ipv e uso da mesma
vacina, método para prevenir ou tratar infecção, e, uso de uma vacina. a dose padrão de vacinas da pélio contém 40 unidades de antígeno d de poliovírus inativados tipo 1 (mahoney), 8 unidades de antígeno d de poliovírus inativados tipo 2 (mef-1), e 32 unidades de antígenos d de poliovírus inativados...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ANNE MARY MICHEL DUCHENE HERVE DE HEMPTINNE MARC SONVEAUX |
| description | vacina, método para prevenir ou tratar infecção, e, uso de uma vacina. a dose padrão de vacinas da pélio contém 40 unidades de antígeno d de poliovírus inativados tipo 1 (mahoney), 8 unidades de antígeno d de poliovírus inativados tipo 2 (mef-1), e 32 unidades de antígenos d de poliovírus inativados tipo 3 (saukett). a presente invenção divulga que doses reduzidas de poliovírus inativados pode manter um nível adequado ou melhorado de proteção contra a pélio.
The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0716518B8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0716518B8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0716518B83</originalsourceid><addsrcrecordid>eNrjZJApS0zOzEtUSElVyCwoU0hVKC3OV0hJVMhNLc5N5GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8U5BAZ4G5oZmpoYWThbGRCkCAJpWI8U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>vacina de ipv e uso da mesma</title><source>esp@cenet</source><creator>ANNE MARY ; MICHEL DUCHENE ; HERVE DE HEMPTINNE ; MARC SONVEAUX</creator><creatorcontrib>ANNE MARY ; MICHEL DUCHENE ; HERVE DE HEMPTINNE ; MARC SONVEAUX</creatorcontrib><description>vacina, método para prevenir ou tratar infecção, e, uso de uma vacina. a dose padrão de vacinas da pélio contém 40 unidades de antígeno d de poliovírus inativados tipo 1 (mahoney), 8 unidades de antígeno d de poliovírus inativados tipo 2 (mef-1), e 32 unidades de antígenos d de poliovírus inativados tipo 3 (saukett). a presente invenção divulga que doses reduzidas de poliovírus inativados pode manter um nível adequado ou melhorado de proteção contra a pélio.
The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.</description><language>por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210525&DB=EPODOC&CC=BR&NR=PI0716518B8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210525&DB=EPODOC&CC=BR&NR=PI0716518B8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANNE MARY</creatorcontrib><creatorcontrib>MICHEL DUCHENE</creatorcontrib><creatorcontrib>HERVE DE HEMPTINNE</creatorcontrib><creatorcontrib>MARC SONVEAUX</creatorcontrib><title>vacina de ipv e uso da mesma</title><description>vacina, método para prevenir ou tratar infecção, e, uso de uma vacina. a dose padrão de vacinas da pélio contém 40 unidades de antígeno d de poliovírus inativados tipo 1 (mahoney), 8 unidades de antígeno d de poliovírus inativados tipo 2 (mef-1), e 32 unidades de antígenos d de poliovírus inativados tipo 3 (saukett). a presente invenção divulga que doses reduzidas de poliovírus inativados pode manter um nível adequado ou melhorado de proteção contra a pélio.
The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJApS0zOzEtUSElVyCwoU0hVKC3OV0hJVMhNLc5N5GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8U5BAZ4G5oZmpoYWThbGRCkCAJpWI8U</recordid><startdate>20210525</startdate><enddate>20210525</enddate><creator>ANNE MARY</creator><creator>MICHEL DUCHENE</creator><creator>HERVE DE HEMPTINNE</creator><creator>MARC SONVEAUX</creator><scope>EVB</scope></search><sort><creationdate>20210525</creationdate><title>vacina de ipv e uso da mesma</title><author>ANNE MARY ; MICHEL DUCHENE ; HERVE DE HEMPTINNE ; MARC SONVEAUX</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0716518B83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ANNE MARY</creatorcontrib><creatorcontrib>MICHEL DUCHENE</creatorcontrib><creatorcontrib>HERVE DE HEMPTINNE</creatorcontrib><creatorcontrib>MARC SONVEAUX</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANNE MARY</au><au>MICHEL DUCHENE</au><au>HERVE DE HEMPTINNE</au><au>MARC SONVEAUX</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>vacina de ipv e uso da mesma</title><date>2021-05-25</date><risdate>2021</risdate><abstract>vacina, método para prevenir ou tratar infecção, e, uso de uma vacina. a dose padrão de vacinas da pélio contém 40 unidades de antígeno d de poliovírus inativados tipo 1 (mahoney), 8 unidades de antígeno d de poliovírus inativados tipo 2 (mef-1), e 32 unidades de antígenos d de poliovírus inativados tipo 3 (saukett). a presente invenção divulga que doses reduzidas de poliovírus inativados pode manter um nível adequado ou melhorado de proteção contra a pélio.
The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BRPI0716518B8 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | vacina de ipv e uso da mesma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A53%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANNE%20MARY&rft.date=2021-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0716518B8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |